Revenio Group Corporation: New share-based Long-term Incentive Plans
Summary
The Board of Directors of Revenio Group Corporation has decided at March 20, 2018 on two new share-based Long-term Incentive Plans for the management team.The common denominators of Revenios business operations include screening, follow-up and the global need to make cost savings through preventive health care.Revenio aims to develop even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health.The focus of Revenios screening technology is on the early detection of glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these during the treatment process.In 2017, net sales of Revenio Group totaled MEUR 26.8, with an operating margin of 35.5%, excluding non-recurring expenses.